Table 8. The effect of surgery on clinical characteristics at 12 and 24 months subdivided by baseline severity.
| Baseline | 12 months | 24 months | ||||||||||||
| Clinical Feature | Minor at baseline | Major at baseline | Total | Minor at baseline | Major at baseline | Total | ||||||||
| Eyes | 1300 | 620 | 608 | 1228* | 613 | 609 | 1222* | |||||||
| Entropion grade | ||||||||||||||
| 0 | 327 | (25.2%) | 598 | (96.5%) | 550 | (90.5%) | 1148 | (93.5%) | 588 | (95.9%) | 538 | (88.3%) | 1126 | (92.1%) |
| 1 | 417 | (32.1%) | 19 | (3.1%) | 34 | (5.6%) | 53 | (4.3%) | 18 | (2.9%) | 44 | (7.2%) | 62 | (5.1%) |
| 2 | 355 | (27.3%) | 3 | (0.5%) | 16 | (2.6%) | 19 | (1.6%) | 7 | (1.1%) | 22 | (3.6%) | 29 | (2.4%) |
| 3 | 122 | (9.4%) | 0 | (0.0%) | 6 | (1.0%) | 6 | (0.5%) | 0 | (0.0%) | 4 | (0.7%) | 4 | (0.3%) |
| 4 | 79 | (6.1%) | 0 | (0.0%) | 2 | (0.3%) | 2 | (0.2%) | 0 | (0.0%) | 1 | (0.2%) | 1 | (0.1%) |
| Conjunctivalisation Grade | ||||||||||||||
| 0 | 9 | (0.7%) | 115 | (18.6%) | 84 | (13.8%) | 199 | (16.2%) | 74 | (12.1%) | 55 | (9.0%) | 129 | (10.6%) |
| 1 | 23 | (1.8%) | 88 | (14.2%) | 88 | (14.5%) | 176 | (14.3%) | 63 | (10.3%) | 68 | (11.2%) | 131 | (10.7%) |
| 2 | 261 | (20.1%) | 258 | (41.6%) | 249 | (40.9%) | 507 | (41.3%) | 309 | (50.4%) | 274 | (45.0%) | 583 | (47.7%) |
| 3 | 1005 | (77.4%) | 159 | (25.7%) | 187 | (13.8%) | 346 | (28.2%) | 167 | (27.2%) | 212 | (34.8%) | 379 | (31.1%) |
*
Total number of participants seen at 12 and 24 months. On occasion, a specific part of the examination was not possible for a particular participant; therefore the total for each examination characteristic is not always identical to these total figures.